Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zeam
    Member
    • Oct 2010
    • 43

    #1

    Is BQSR necessary for de novo mutation calling?

    Hi there,
    I have been using GATK to identify variants recently. I saw that BQSR is highly recommended. But I don’t whether it is still needed for de novo mutation calling. For example, I want to identify de novo mutations generated in the progenies by single seed descent methods in plants. For example, in the paper of “The rate and molecular spectrum of spontaneous mutations in Arabidopsis thaliana”, these spontaneous arising mutations may not included in the known sites of variants. Based on documentation posted in GATK websites, they assume that all reference mismatches we see are therefore errors and indicative of poor base quality. Under this assumption, these de novo mutations may be missed in the step of variant calling. So in this situation, what should I do? Or should I skip the BQSR step?
    Also what should I do when I reach to step- VQSR?
    Hope some GATK developers can help me on this.
    Thanks.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...